Real-time enrollment status for this hereditary spastic paraplegia type 50 clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:23 PM UTC
| NCT Number | NCT06692712 |
| Recruiting Status | Recruiting |
| Condition | Hereditary Spastic Paraplegia Type 50 |
| Phase | Clinical Trial |
| Target Enrollment | 24 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Elpida Therapeutics SPC |
| Last Updated on CT.gov | April 20, 2026 (Apr 20, 2026) |
As of July 13, 2026: Clinical trial NCT06692712 is currently recruiting participants. This clinical trial study for hereditary spastic paraplegia type 50 is actively seeking new participants at 1 location across the United States. The study is sponsored by Elpida Therapeutics SPC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06692712 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06692712 was last updated Apr 20, 2026 (April 20, 2026). HelloStudys verifies this status automatically.